2022 Q3 Form 10-Q Financial Statement

#000121390022055805 Filed on September 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q3
Revenue $3.734K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $21.96K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $0.00 $21.96K
YoY Change -100.0%
Operating Profit -$181.3K -$178.0K
YoY Change 1.83%
Interest Expense $2.137K $12.50K
YoY Change -82.9%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$179.7K -$190.5K
YoY Change -5.71%
Income Tax
% Of Pretax Income
Net Earnings -$178.2K -$158.5K
YoY Change 12.43%
Net Earnings / Revenue -4771.05%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 105.7M shares 47.64M shares
Diluted Shares Outstanding 105.7M shares 47.64M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $277.3K $437.2K $613.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $1.458K
Other Receivables
Total Short-Term Assets $279.7K $439.6K
YoY Change -40.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $279.7K $439.6K
Total Long-Term Assets $0.00 $0.00
Total Assets $279.7K $439.6K
YoY Change -40.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $326.3K
YoY Change 0.0%
Accrued Expenses $63.77K $65.71K
YoY Change -9.32%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $895.6K $884.9K
YoY Change 43.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $895.6K $884.9K
Total Long-Term Liabilities
Total Liabilities $895.6K $902.9K
YoY Change 6.44%
SHAREHOLDERS EQUITY
Retained Earnings -$5.495M -$4.433M
YoY Change 23.72%
Common Stock $586.1K $613.7K $11.00K
YoY Change 5227.82% -31.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$909.8K $177.6K
YoY Change
Total Liabilities & Shareholders Equity $279.7K $439.6K
YoY Change -40.14%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q3
OPERATING ACTIVITIES
Net Income -$178.2K -$158.5K
YoY Change 12.43%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$155.8K -$126.9K
YoY Change 22.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $27.30K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $45.00 $27.30K
YoY Change -99.84%
NET CHANGE
Cash From Operating Activities -$155.8K -$126.9K
Cash From Investing Activities
Cash From Financing Activities $45.00 $27.30K
Net Change In Cash -$159.9K -$86.20K
YoY Change 85.46%
FREE CASH FLOW
Cash From Operating Activities -$155.8K -$126.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-07-31
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
Sensasure Technologies Inc.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q3 dei Entity File Number
EntityFileNumber
001-41209
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2406468
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
505 Park Ave.
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2022Q3 dei City Area Code
CityAreaCode
(347)
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
325-4677
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2022Q3 dei Trading Symbol
TradingSymbol
SESU
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105723183 shares
CY2022Q3 us-gaap Cash
Cash
256925 usd
CY2022Q2 us-gaap Cash
Cash
46419 usd
CY2022Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
20393 usd
CY2022Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
390758 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1458 usd
CY2022Q3 sesu Prepayments And Other Receivables
PrepaymentsAndOtherReceivables
924 usd
CY2022Q2 sesu Prepayments And Other Receivables
PrepaymentsAndOtherReceivables
2468 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
279700 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
439645 usd
CY2022Q3 us-gaap Assets
Assets
279700 usd
CY2022Q2 us-gaap Assets
Assets
439645 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
95533 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
117892 usd
CY2022Q3 sesu Accounts Payable And Accrued Liabilities To A Related Party
AccountsPayableAndAccruedLiabilitiesToARelatedParty
408566 usd
CY2022Q2 sesu Accounts Payable And Accrued Liabilities To A Related Party
AccountsPayableAndAccruedLiabilitiesToARelatedParty
407163 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
74875 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
76638 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
84493 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
86482 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
232136 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
196740 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
895603 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
884915 usd
CY2022Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
17935 usd
CY2022Q3 us-gaap Liabilities
Liabilities
895603 usd
CY2022Q2 us-gaap Liabilities
Liabilities
902850 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105723183 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105723183 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105723183 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105723183 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
575060 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
564060 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4246080 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4242504 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-235688 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-195610 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5495271 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4433352 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-909819 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
177602 usd
CY2022Q3 us-gaap Noncontrolling Interest In Variable Interest Entity
NoncontrollingInterestInVariableInterestEntity
53275 usd
CY2022Q2 us-gaap Noncontrolling Interest In Variable Interest Entity
NoncontrollingInterestInVariableInterestEntity
-881448 usd
CY2022Q3 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
240641 usd
CY2022Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
240641 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-615903 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-463205 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279700 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
439645 usd
CY2022Q3 us-gaap Revenues
Revenues
3734 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
181268 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
156054 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21964 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-181268 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-178018 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
2137 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
12498 usd
CY2021Q3 sesu Other Incomeexpenses
OtherIncomeexpenses
-27 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-179671 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-190543 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-179671 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-190543 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1520 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32089 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-178151 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-158454 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105723183 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47636922 shares
CY2022Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-179671 usd
CY2021Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-190543 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12352 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14467 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-167319 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-176076 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
166597 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
147749 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-722 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-28327 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-167319 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-176076 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-463205 usd
CY2022Q3 sesu Subsidiary Issuance Of Shares Pursuant To Private Placement
SubsidiaryIssuanceOfSharesPursuantToPrivatePlacement
45 usd
CY2022Q3 sesu Amortization Of Vested Shares
AmortizationOfVestedShares
14576 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-179671 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
12352 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-615903 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-113692 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
25131 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-190543 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
14467 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-264637 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-179671 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-190543 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
14576 usd
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
25131 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1451 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-578 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1478 usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3013 usd
CY2022Q3 sesu Accounts Payable And Accrued Liabilities To Third Parties And A Related Party
AccountsPayableAndAccruedLiabilitiesToThirdPartiesAndARelatedParty
-13051 usd
CY2021Q3 sesu Accounts Payable And Accrued Liabilities To Third Parties And A Related Party
AccountsPayableAndAccruedLiabilitiesToThirdPartiesAndARelatedParty
-9879 usd
CY2022Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
39738 usd
CY2021Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
44838 usd
CY2022Q3 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-17443 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-155824 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126862 usd
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27300 usd
CY2022Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
45 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27300 usd
CY2022Q3 sesu Effect Of Exchange Rate Changes On Cash And Restricted Cash Held In Trust
EffectOfExchangeRateChangesOnCashAndRestrictedCashHeldInTrust
-4080 usd
CY2021Q3 sesu Effect Of Exchange Rate Changes On Cash And Restricted Cash Held In Trust
EffectOfExchangeRateChangesOnCashAndRestrictedCashHeldInTrust
13366 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-159859 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-86196 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
437177 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
699777 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
277318 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
613581 usd
CY2021Q2 sesu Proceeds Received In Common Stock
ProceedsReceivedInCommonStock
117800 usd
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
647900 usd
CY2021Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
27300 usd
CY2020Q4 sesu Description Of Share Exchange Agreement
DescriptionOfShareExchangeAgreement
Under the share exchange agreement, the shareholders of Sensa Bues AB, agreed to exchange their shares of Sensa Bues AB for common shares of SensaSure at an exchange ratio of approximate 1:49.99. Pursuant to the share exchange transactions (see share exchange agreement noted above), SensaSure issued a total of 13,515,183 common shares and the then-shareholders of Sensa Bues AB hold their ownership of Sensa Bues AB through SensaSure (Note 8 (b)). Upon completion of the share exchange transaction, SensaSure became the controlling shareholder that owned 74.82% the total issued and outstanding common shares in Sensa Bues AB and parent company of Sensa Bues AB (“Subsidiary”).
CY2022Q3 sesu Common Stock Share Issued
CommonStockShareIssued
2200000 shares
CY2022Q3 sesu Common Shares Noncontrolling Interests
CommonSharesNoncontrollingInterests
440 shares
CY2022Q3 sesu Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.9353 pure
CY2022Q2 sesu Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.74 pure
CY2022Q3 sesu Working Capital Deficiency
WorkingCapitalDeficiency
615903 usd
CY2022Q2 sesu Working Capital Deficiency
WorkingCapitalDeficiency
445270 usd
CY2022Q2 sesu Several Private Placements
SeveralPrivatePlacements
368200 usd
CY2021Q2 sesu Several Private Placements
SeveralPrivatePlacements
893014 usd
CY2021Q1 us-gaap Gas Imbalance Payable Current And Noncurrent
GasImbalancePayableCurrentAndNoncurrent
333744 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
326337 usd
CY2022 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
420000 shares
CY2022Q3 sesu Proceeds Received From Common Stock Issued
ProceedsReceivedFromCommonStockIssued
420000 shares
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-size: 10pt">(d)</span></td> <td><span style="font-size: 10pt"><b>Critical management judgment and use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of the condensed interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance, accruals, stock options, principles of consolidation and reverse recapitalization and assumptions used in the going concern assessment. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p>
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65714 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
95533 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
117892 usd
CY2020Q4 sesu Owned Common Shares Percentage
OwnedCommonSharesPercentage
0.7282 pure
CY2020Q4 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
13515183 shares
CY2022Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
176280 sek
CY2022Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
408566 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105723183 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105723183 shares
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
99643 usd
CY2021 sesu Common Shares To Noncontrolling Interests
CommonSharesToNoncontrollingInterests
10000 shares
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
499935 shares
CY2021 us-gaap Proceeds From Customers
ProceedsFromCustomers
4999 usd
CY2021Q2 us-gaap Common Stocks Including Additional Paid In Capital Net Of Discount
CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount
94644 usd
CY2020Q4 sesu Owned Common Shares
OwnedCommonShares
270339 shares
CY2021 sesu Proceeds Net
ProceedsNet
793000 usd
CY2021 sesu Proceed From Issuance Of Common Stock
ProceedFromIssuanceOfCommonStock
12200000 shares
CY2021 sesu Issued Of Common Shares
IssuedOfCommonShares
11780000 shares
CY2022Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
31768 usd
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
52178 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63765 usd
CY2022Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
29125 usd
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
293000 sek
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
29811 usd
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
293000 sek
CY2022Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.20 pure
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
1359 usd
CY2021Q3 us-gaap Interest Expense Other
InterestExpenseOther
1711 usd
CY2021Q1 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
326337 usd
CY2021Q1 sesu Aggregated Shares
AggregatedShares
3400 shares
CY2021Q1 sesu Number Of Common Shares
NumberOfCommonShares
50 shares
CY2022Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
29821 usd
CY2022Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0 sek
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
30523 usd
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0 sek
CY2022Q3 sesu Unsecured Bearing Interest
UnsecuredBearingInterest
0.02 pure
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
165 usd
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
177 usd
CY2022Q3 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
138483 usd
CY2022Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
138483 usd
CY2021Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
333744 usd
CY2021Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
2798280 sek
CY2022Q2 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
6997 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
263247 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
2648280 sek
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
261683 usd
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
2572000 sek
CY2022Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
17935 usd
CY2022Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
407163 usd
CY2021Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
21964 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Accelerated Share Repurchases Cash Or Stock Settlement
AcceleratedShareRepurchasesCashOrStockSettlement
Eighteen (18) months after the initial listing date of the shares on the NASDAQ Market, the Shareholder shall have 1,914,704 shares available to sell. Twenty-four (24) months after the initial listing date of the shares on the NASDAQ Market, the Shareholders shall have 5,744,109 shares available to sell.
CY2021 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
793000 usd
CY2021 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
12200000 shares
CY2021 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
11780000 shares
CY2021 sesu Agreement Description
AgreementDescription
The proceeds received was reflected as an increase in common stock in amount of $117,800 and additional paid-in capital in amount of $647,900 respectively. The Company recognized a subscription receivable in amount of $27,300 as well as shares to be issued at April 30, 2021. The number of shares to be issued was 420,000. The Company received the subscription proceeds for the three months ended July 31, 2021 and issued 420,000 common shares accordingly (Note 4). The subscribers entered into lock up agreement pursuant to which (i) The Shareholders shall have 1,715,800 of the shares subscribed to sell when a trading market begins on the OTC Markets; (ii) The Shareholders shall have 5,346,000 of their remaining shares available to sell Six (6) months after the initial listing date of the shares on the NASDAQ Market; (iii) The Shareholders shall have their remaining shares for trading Eighteen (18) months after the initial listing date of the shares on the NASDAQ Market; and (iv) In the event the stock does not begin trading on the NASDAQ Market within a period of Thirty-Six (36) months after the execution of the Share Exchange Agreement, the Shareholders shall have up to Thirty Percent (30%) of their remaining shares available to sell after the initial listing date of the shares on the OTC Market. The balance of the Shareholder’s shares shall be available for trading Sixty (60) months after the initial listing date of the shares on the OTC Market (the “Lock Up Period”)
CY2022 sesu Shares Available Description
SharesAvailableDescription
After the revision, the shareholders shall have 10,898,736 shares available to sell upon a trading market begins on OTC Market, 7,738,000 shares available to sell upon six months after a trading market begins on OTC Market, 4,750,000 shares available to sell upon initial listing date on the Nasdaq Market, 6,280,000 shares available to sell upon six months after initial listing date on the Nasdaq Market, 800,000 shares available to sell upon twelve months after initial listing date on the Nasdaq Market, 3,838,213 shares available to sell upon eighteen months after the initial listing date on Nasdaq Market, 6,620,863 shares available to sell upon twenty four months after the initial listing date on Nasdaq Market and the balance of the shareholders’ shares will be available to sell upon sixty months after the initial listing date on Nasdaq Market.
CY2021Q2 sesu Fair Value Of Shares Issued Amount
FairValueOfSharesIssuedAmount
502614 usd
CY2021Q3 us-gaap Other Expense From Real Estate Partnership Operations
OtherExpenseFromRealEstatePartnershipOperations
25131 usd
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11000 usd
CY2021Q3 us-gaap Common Stocks Including Additional Paid In Capital Net Of Discount
CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount
14131 usd
CY2022 sesu Unvested Shares
UnvestedShares
7931000 shares
CY2022Q3 sesu Common Stock In Amount
CommonStockInAmount
14576 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11000 usd
CY2022Q3 us-gaap Common Stocks Including Additional Paid In Capital Net Of Discount
CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount
3576 usd
CY2021 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
31500 shares
CY2022Q2 sesu Common Shares
CommonShares
50 shares
CY2021Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
27300 usd
CY2022 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
420000 shares
CY2022Q2 sesu Proceeds Received From Common Stock Issued
ProceedsReceivedFromCommonStockIssued
420000 shares
CY2022 us-gaap Payments For Repurchase Of Private Placement
PaymentsForRepurchaseOfPrivatePlacement
340900 usd
CY2022 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
0.07
CY2022 sesu Agreement Description
AgreementDescription
The proceeds received was reflected as an increase in common stock in amount of $3,409 and additional paid-in capital in amount of $337,491 respectively. The subscribers entered into lock up agreement and the shareholders shall have 502,584 shares available to sell upon a trading market begins on OTC Market, 356,484 shares available to sell upon six months after a trading market begins on OTC Market, 218,663 shares available to sell upon initial listing date on the Nasdaq Market, 289,278 shares available to sell upon six months after initial listing date on the Nasdaq Market, 37,012 shares available to sell upon twelve months after initial listing date on the Nasdaq Market, 176,781 shares available to sell upon eighteen months after the initial listing date on Nasdaq Market, 304,862 shares available to sell upon twenty four months after the initial listing date on Nasdaq Market and the balance of the shareholders’ shares will be available to sell upon sixty months after the initial listing date on Nasdaq Market.
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
April 30, 2022, the Company approved the issuance of 2,118,000 shares of the common stock to several consultants and directors. The fair value of the share-based compensation was in the amount of $148,260 and was included in the general and admirative expenses as well as a credit made in common stock in amount of 21,180 and additional paid-in capital in amount of 127,080 respectively. The fair value of the shares of common stock issued was determined by using the most recent private placement price at $0.07 per share. One of the consultants is a related party individual and the share awards was 2,100,000 common shares with an amount of 147,000.During the year ended April 30, 2022, SensaSure issued 3,080,000 common stock to a consultant of the Company for services to be provided in future including completion of certain financing projects and regulatory services. The fair value of the shares of common stock issued was determined by using the most recent private placement price at $0.07 per share. At April 30, 2022, none of these services were rendered. Accordingly, the Company has not recognized any share based compensation expense during the year. 
CY2022Q3 sesu Common Share
CommonShare
2200000 shares
CY2022Q3 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
225641 usd
CY2022Q3 sesu Common Shareholders Of The Company Percentage
CommonShareholdersOfTheCompanyPercentage
0.9353 pure
CY2022 sesu Common Shareholders Of The Company Percentage
CommonShareholdersOfTheCompanyPercentage
0.74 pure
CY2021 sesu Common Shareholders Of The Company Percentage
CommonShareholdersOfTheCompanyPercentage
0.74 pure
CY2022Q3 sesu Noncontrolling Interests Percentage
NoncontrollingInterestsPercentage
0.0647 pure
CY2022Q2 sesu Noncontrolling Interests Percentage
NoncontrollingInterestsPercentage
0.26 pure
CY2021Q2 sesu Noncontrolling Interests Percentage
NoncontrollingInterestsPercentage
0.26 pure
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-178151 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-158454 usd
CY2022Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-883768 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1061919 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-158544 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q2 sesu Preferred Stock Value1
PreferredStockValue1
usd
CY2022Q3 sesu Common Stock Value1
CommonStockValue1
usd
CY2022Q2 sesu Common Stock Value1
CommonStockValue1
usd
CY2022Q2 us-gaap Shares Issued
SharesIssued
420000 shares
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022Q3 sesu Other Incomeexpenses
OtherIncomeexpenses
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.003
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105723183 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47636922 shares
CY2022Q3 sesu Effect Of Dilution Of Ownership In Subsidiary Pursuant To Issuance Of Shares
EffectOfDilutionOfOwnershipInSubsidiaryPursuantToIssuanceOfShares
usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2021Q3 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2021Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
usd
CY2021Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
sek
CY2022Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
usd
CY2022Q3 us-gaap Other Minority Interests
OtherMinorityInterests
usd
CY2021Q3 us-gaap Other Minority Interests
OtherMinorityInterests
usd
CY2021Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
usd
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001885336
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NONE

Files In Submission

Name View Source Status
0001213900-22-055805-index-headers.html Edgar Link pending
0001213900-22-055805-index.html Edgar Link pending
0001213900-22-055805.txt Edgar Link pending
0001213900-22-055805-xbrl.zip Edgar Link pending
f10q0722ex31-1_sensasuretech.htm Edgar Link pending
f10q0722ex31-2_sensasuretech.htm Edgar Link pending
f10q0722ex32-1_sensasuretech.htm Edgar Link pending
f10q0722ex32-2_sensasuretech.htm Edgar Link pending
f10q0722_sensasuretech.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sesu-20220731.xsd Edgar Link pending
Show.js Edgar Link pending
sesu-20220731_def.xml Edgar Link unprocessable
f10q0722_sensasuretech_htm.xml Edgar Link completed
sesu-20220731_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sesu-20220731_pre.xml Edgar Link unprocessable
sesu-20220731_cal.xml Edgar Link unprocessable